Navellier & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.21M | Sell |
11,971
-467
| -4% | -$166K | 0.44% | 53 |
|
|
2025
Q4 | $4.07M | Sell |
12,438
-1,013
| -8% | -$321K | 0.46% | 53 |
|
|
2025
Q3 | $3.8M | Buy |
13,451
+230
| +2% | +$66.7K | 0.39% | 71 |
|
|
2025
Q2 | $3.69M | Sell |
13,221
-29
| -0.2% | -$8.22K | 0.46% | 62 |
|
|
2025
Q1 | $3.71M | Sell |
13,250
-1,395
| -10% | -$412K | 0.51% | 53 |
|
|
2024
Q4 | $3.82M | Sell |
14,645
-172
| -1% | -$51K | 0.46% | 56 |
|
|
2024
Q3 | $4.77M | Sell |
14,817
-681
| -4% | -$223K | 0.65% | 39 |
|
|
2024
Q2 | $4.84M | Sell |
15,498
-231
| -1% | -$67.9K | 0.57% | 42 |
|
|
2024
Q1 | $4.47M | Sell |
15,729
-5,186
| -25% | -$1.52M | 0.55% | 45 |
|
|
2023
Q4 | $6.02M | Buy |
20,915
+1,051
| +5% | +$286K | 0.9% | 25 |
|
|
2023
Q3 | $5.34M | Sell |
19,864
-589
| -3% | -$147K | 0.91% | 21 |
|
|
2023
Q2 | $4.54M | Buy |
20,453
+24
| +0.1% | +$5.57K | 0.88% | 29 |
|
|
2023
Q1 | $4.94M | Sell |
20,429
-364
| -2% | -$89.4K | 1.04% | 16 |
|
|
2022
Q4 | $5.46M | Buy |
20,793
+1,255
| +6% | +$336K | 1.11% | 22 |
|
|
2022
Q3 | $4.4M | Sell |
19,538
-103
| -0.5% | -$25K | 0.98% | 28 |
|
|
2022
Q2 | $4.78M | Buy |
19,641
+570
| +3% | +$140K | 1.03% | 27 |
|
|
2022
Q1 | $4.61M | Buy |
19,071
+675
| +4% | +$155K | 0.78% | 39 |
|
|
2021
Q4 | $4.14M | Sell |
18,396
-773
| -4% | -$163K | 0.6% | 59 |
|
|
2021
Q3 | $4.08M | Sell |
19,169
-282
| -1% | -$64.9K | 0.61% | 55 |
|
|
2021
Q2 | $4.74M | Buy |
19,451
+897
| +5% | +$221K | 0.72% | 44 |
|
|
2021
Q1 | $4.62M | Sell |
18,554
-197
| -1% | -$47K | 0.83% | 37 |
|
|
2020
Q4 | $4.31M | Sell |
18,751
-645
| -3% | -$149K | 0.78% | 42 |
|
|
2020
Q3 | $4.93M | Sell |
19,396
-332
| -2% | -$82.2K | 1.08% | 29 |
|
|
2020
Q2 | $4.65M | Sell |
19,728
-336
| -2% | -$76.7K | 1.11% | 25 |
|
|
2020
Q1 | $4.07M | Sell |
20,064
-794
| -4% | -$173K | 0.96% | 23 |
|
|
2019
Q4 | $5.03M | Sell |
20,858
-590
| -3% | -$130K | 0.81% | 36 |
|
|
2019
Q3 | $4.15M | Buy |
21,448
+455
| +2% | +$87.3K | 0.69% | 36 |
|
|
2019
Q2 | $3.87M | Sell |
20,993
-112
| -0.5% | -$20.1K | 0.6% | 42 |
|
|
2019
Q1 | $4.01M | Sell |
21,105
-675
| -3% | -$129K | 0.62% | 39 |
|
|
2018
Q4 | $4.24M | Sell |
21,780
-676
| -3% | -$132K | 0.72% | 26 |
|
|
2018
Q3 | $4.66M | Sell |
22,456
-720
| -3% | -$142K | 0.6% | 45 |
|
|
2018
Q2 | $4.28M | Buy |
23,176
+353
| +2% | +$62.4K | 0.6% | 42 |
|
|
2018
Q1 | $3.89M | Buy |
22,823
+617
| +3% | +$113K | 0.59% | 40 |
|
|
2017
Q4 | $3.86M | Sell |
22,206
-3,794
| -15% | -$671K | 0.72% | 37 |
|
|
2017
Q3 | $4.85M | Sell |
26,000
-12,500
| -32% | -$2.21M | 0.94% | 30 |
|
|
2017
Q2 | $6.63M | Sell |
38,500
-2,500
| -6% | -$407K | 0.99% | 22 |
|
|
2017
Q1 | $6.73M | Sell |
41,000
-1,200
| -3% | -$199K | 0.98% | 26 |
|
|
2016
Q4 | $6.17M | Sell |
42,200
-2,801
| -6% | -$422K | 1.02% | 22 |
|
|
2016
Q3 | $7.51M | Sell |
45,001
-678
| -1% | -$115K | 1.07% | 32 |
|
|
2016
Q2 | $6.95M | Buy |
45,679
+1,278
| +3% | +$199K | 1.04% | 41 |
|
|
2016
Q1 | $6.66M | Buy |
44,401
+2,497
| +6% | +$371K | 0.86% | 41 |
|
|
2015
Q4 | $6.8M | Sell |
41,904
-450
| -1% | -$70.7K | 0.75% | 41 |
|
|
2015
Q3 | $5.86M | Buy |
42,354
+821
| +2% | +$129K | 0.59% | 42 |
|
|
2015
Q2 | $6.38M | Buy |
41,533
+5,872
| +16% | +$941K | 0.56% | 34 |
|
|
2015
Q1 | $5.7M | Buy |
35,661
+2,092
| +6% | +$329K | 0.52% | 33 |
|
|
2014
Q4 | $5.35M | Buy |
33,569
+3,532
| +12% | +$550K | 0.27% | 38 |
|
|
2014
Q3 | $4.22M | Buy |
30,037
+2,078
| +7% | +$271K | 0.21% | 38 |
|
|
2014
Q2 | $3.31M | Sell |
27,959
-262,403
| -90% | -$30.4M | 0.15% | 45 |
|
|
2014
Q1 | $35.8M | Sell |
290,362
-12,780
| -4% | -$1.55M | 1.67% | 34 |
|
|
2013
Q4 | $34.6M | Sell |
303,142
-21,645
| -7% | -$2.46M | 1.56% | 36 |
|
|
2013
Q3 | $36.4M | Sell |
324,787
-8,810
| -3% | -$955K | 1.07% | 51 |
|
|
2013
Q2 | $32.9M | Buy |
+333,597
| New | +$34.6M | 1.57% | 34 |
|
Other funds holding AMGN
VCM
VPM
Navellier & Associates's AMGN Position: Q1 2026 in Review
Navellier & Associates reduced its Amgen (AMGN) stake by 3.8% in Q1 2026, selling an estimated $166K and leaving 11,971 shares worth $4.21M. The position accounts for 0.44% of the portfolio, ranked #53.
Navellier & Associates first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.4M in Q3 2013. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Navellier & Associates held 11,971 shares of Amgen worth $4.21M as of Q1 2026.
- Navellier & Associates sold 467 Amgen shares in Q1 2026, an estimated $166K.
- Amgen made up 0.44% of Navellier & Associates's portfolio in Q1 2026, its #53 holding.
- Navellier & Associates first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Navellier & Associates's Amgen position peaked at $36.4M in Q3 2013.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.